PUMA BIOTECHNOLOGY, INC.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | $-292.0M | $-276.0M | $-239.3M | $-142.0M | $-54.7M | $-74.4M | $-10.2M |
| Depreciation & Amortization | $2.8M | $1.1M | $776.0K | $627.0K | $423.0K | $265.0K | $11.0K |
| Depreciation | $1.1M | — | — | — | — | — | — |
| Amortization | $1.6M | — | — | — | — | — | — |
| Stock-Based Compensation | $108.7M | $117.3M | $94.9M | $39.2M | $7.5M | $19.6M | $67.0K |
| Net Cash from Operating Activities | $-172.5M | $-141.7M | $-154.5M | $-77.2M | $-55.0M | $-44.0M | $-1.8M |
| Investing Activities | |||||||
| Capital Expenditures | $431.0K | $4.3M | $1.0M | $1.1M | $624.0K | — | $253.3K |
| Business Acquisitions | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-15.4M | $142.2M | — | — | $-41.5M | $-1.2M | $-1.7M |
| Financing Activities | |||||||
| Dividends Paid | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $75.1M | $162.4M | — | — | $2.2M | $129.3M | $57.0M |
| Net Change in Cash | $-112.8M | $162.9M | $-7.0M | $-4.5M | $-94.4M | $84.0M | $53.4M |
| Free Cash Flow | $-172.9M | $-146.0M | $-155.5M | $-78.3M | $-55.7M | — | $-2.1M |